Phytochemical portfolio and anticancer activity of Murraya koenigii and its primary active component, mahanine
- PMID: 29175114
- DOI: 10.1016/j.phrs.2017.11.024
Phytochemical portfolio and anticancer activity of Murraya koenigii and its primary active component, mahanine
Abstract
Murraya koenigii, a plant belonging to the Rutaceae family is widely distributed in Eastern-Asia and its medicinal properties are well documented in Ayurveda, the traditional Indian system of medicine. Through systematic research and pharmacological evaluation of different parts of the plant extracts has been shown to possess antiviral, anti-inflammatory, antioxidant, antidiabetic, antidiarrhoeal, antileishmanial, and antitumor activity. In the plant extracts, carbazole alkaloid, mahanine has been identified as the principle bioactive component among several other chemical constituents. Scientific evidence derived not only from in vitro cellular experiments but also from in vivo studies in various cancer models is accumulating for the pronounced anticancer effects of mahanine. The primary objective of this review is to summarize research data on cytotoxic chemical constituents present in different parts of Murraya koenigii and the anticancer activity of mahanine along with the recent understanding on the mechanism of its action in diverse cancer models. The information on its bioavailability and the toxicity generated from the recent studies have also been incorporated in the review.
Keywords: Anticancer; Bioactive; Chemical constituent; Mahanine; Murraya koenigii.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Similar articles
-
Preclinical Development of Mahanine-Enriched Fraction from Indian Spice Murraya koenigii for the Management of Cancer: Efficacy, Temperature/pH stability, Pharmacokinetics, Acute and Chronic Toxicity (14-180 Days) Studies.Biomed Res Int. 2020 Aug 10;2020:4638132. doi: 10.1155/2020/4638132. eCollection 2020. Biomed Res Int. 2020. PMID: 32851075 Free PMC article.
-
Chemopreventive potential of hydroethanolic Murraya koenigii leaves extract against DMBA induced breast carcinogenesis: In-silico and in-vivo study.J Ethnopharmacol. 2024 Jan 30;319(Pt 1):117124. doi: 10.1016/j.jep.2023.117124. Epub 2023 Sep 8. J Ethnopharmacol. 2024. PMID: 37678421
-
RP-HPLC-DAD for simultaneous estimation of mahanine and mahanimbine in Murraya koenigii.Biomed Chromatogr. 2011 Sep;25(9):959-62. doi: 10.1002/bmc.1561. Epub 2011 Mar 4. Biomed Chromatogr. 2011. PMID: 21381062
-
Murraya koenigii (L.) Spreng. as a Natural Intervention for Diabesity: A Review.Curr Pharm Des. 2024;30(41):3255-3275. doi: 10.2174/0113816128304471240801183021. Curr Pharm Des. 2024. PMID: 39253925 Review.
-
An update on Murraya koenigii spreng: a multifunctional Ayurvedic herb.Zhong Xi Yi Jie He Xue Bao. 2011 Aug;9(8):824-33. Zhong Xi Yi Jie He Xue Bao. 2011. PMID: 21849142 Review.
Cited by
-
Metabolomic approach for phytochemical assessment of Murraya koenigii fruits during different maturity stages.Heliyon. 2023 Jul 29;9(8):e18688. doi: 10.1016/j.heliyon.2023.e18688. eCollection 2023 Aug. Heliyon. 2023. PMID: 37576304 Free PMC article.
-
Identification of microRNAs from Medicinal Plant Murraya koenigii by High-Throughput Sequencing and Their Functional Implications in Secondary Metabolite Biosynthesis.Plants (Basel). 2021 Dec 24;11(1):46. doi: 10.3390/plants11010046. Plants (Basel). 2021. PMID: 35009050 Free PMC article.
-
Multi-Target Approach of Murraya koenigii Leaves in Treating Neurodegenerative Diseases.Pharmaceuticals (Basel). 2022 Feb 2;15(2):188. doi: 10.3390/ph15020188. Pharmaceuticals (Basel). 2022. PMID: 35215300 Free PMC article. Review.
-
Mukonal exerts anticancer effects on the human breast cancer cells by inducing autophagy and apoptosis and inhibits the tumor growth in vivo.AMB Express. 2020 Aug 18;10(1):148. doi: 10.1186/s13568-020-01074-8. AMB Express. 2020. PMID: 32809085 Free PMC article.
-
Anticancer Activity of Mukonal Against Human Laryngeal Cancer Cells Involves Apoptosis, Cell Cycle Arrest, and Inhibition of PI3K/AKT and MEK/ERK Signalling Pathways.Med Sci Monit. 2018 Oct 12;24:7295-7302. doi: 10.12659/MSM.910702. Med Sci Monit. 2018. Retraction in: Med Sci Monit. 2022 Jul 19;28:e937840. doi: 10.12659/MSM.937840. PMID: 30312287 Free PMC article. Retracted.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources